Shan Lung Announces Board of Directors' Approval of Q1 2026 Consolidated Financial Report
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Shan Lung's Board of Directors approved its Q1 2026 consolidated financial report for the period from January 1 to March 31, 2026. Despite robust operating revenue of NT$1.95 billion, the company reported an operating loss of NT$176.37 million and a basic EPS of -NT$1.37, indicating a challenging quarter.